Logo image of CMBT.BR

CMB TECH NV (CMBT.BR) Stock Fundamental Analysis

EBR:CMBT - Euronext Brussels - BE0003816338 - Common Stock - Currency: EUR

7.72  -0.01 (-0.13%)

Fundamental Rating

4

Overall CMBT gets a fundamental rating of 4 out of 10. We evaluated CMBT against 62 industry peers in the Oil, Gas & Consumable Fuels industry. While CMBT belongs to the best of the industry regarding profitability, there are concerns on its financial health. CMBT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CMBT was profitable.
In the past year CMBT had a positive cash flow from operations.
CMBT had positive earnings in 4 of the past 5 years.
Of the past 5 years CMBT 4 years had a positive operating cash flow.
CMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFCMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

CMBT has a better Return On Assets (12.31%) than 90.32% of its industry peers.
The Return On Equity of CMBT (79.11%) is better than 96.77% of its industry peers.
With a Return On Invested Capital value of 5.06%, CMBT is not doing good in the industry: 64.52% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for CMBT is significantly below the industry average of 14.65%.
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROIC 5.06%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)8.95%
ROIC(5y)N/A
CMBT.BR Yearly ROA, ROE, ROICCMBT.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

CMBT's Profit Margin of 72.50% is amongst the best of the industry. CMBT outperforms 98.39% of its industry peers.
In the last couple of years the Profit Margin of CMBT has grown nicely.
CMBT has a Operating Margin of 35.88%. This is amongst the best in the industry. CMBT outperforms 80.65% of its industry peers.
In the last couple of years the Operating Margin of CMBT has grown nicely.
CMBT's Gross Margin of 58.65% is fine compared to the rest of the industry. CMBT outperforms 67.74% of its industry peers.
In the last couple of years the Gross Margin of CMBT has remained more or less at the same level.
Industry RankSector Rank
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBT.BR Yearly Profit, Operating, Gross MarginsCMBT.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CMBT is creating some value.
CMBT has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CMBT has less shares outstanding
Compared to 1 year ago, CMBT has a worse debt to assets ratio.
CMBT.BR Yearly Shares OutstandingCMBT.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT.BR Yearly Total Debt VS Total AssetsCMBT.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CMBT has an Altman-Z score of 0.66. This is a bad value and indicates that CMBT is not financially healthy and even has some risk of bankruptcy.
CMBT's Altman-Z score of 0.66 is on the low side compared to the rest of the industry. CMBT is outperformed by 79.03% of its industry peers.
A Debt/Equity ratio of 3.75 is on the high side and indicates that CMBT has dependencies on debt financing.
CMBT has a Debt to Equity ratio of 3.75. This is amonst the worse of the industry: CMBT underperforms 93.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Altman-Z 0.66
ROIC/WACC0.67
WACC7.53%
CMBT.BR Yearly LT Debt VS Equity VS FCFCMBT.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

CMBT has a Current Ratio of 0.77. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.77, CMBT is doing worse than 88.71% of the companies in the same industry.
A Quick Ratio of 0.70 indicates that CMBT may have some problems paying its short term obligations.
With a Quick ratio value of 0.70, CMBT is not doing good in the industry: 88.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.7
CMBT.BR Yearly Current Assets VS Current LiabilitesCMBT.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

CMBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -79.01%.
Measured over the past years, CMBT shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.41% on average per year.
CMBT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.34%.
The Revenue has been growing slightly by 0.55% on average over the past years.
EPS 1Y (TTM)-79.01%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-100.41%
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-2.22%

3.2 Future

The Earnings Per Share is expected to decrease by -29.06% on average over the next years. This is quite bad
Based on estimates for the next years, CMBT will show a quite strong growth in Revenue. The Revenue will grow by 9.37% on average per year.
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue Next Year7.15%
Revenue Next 2Y15.37%
Revenue Next 3Y9.37%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBT.BR Yearly Revenue VS EstimatesCMBT.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CMBT.BR Yearly EPS VS EstimatesCMBT.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.35, which indicates a rather cheap valuation of CMBT.
Based on the Price/Earnings ratio, CMBT is valued a bit cheaper than 79.03% of the companies in the same industry.
CMBT is valuated cheaply when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 5.43, which indicates a rather cheap valuation of CMBT.
CMBT's Price/Forward Earnings ratio is rather cheap when compared to the industry. CMBT is cheaper than 88.71% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.70. CMBT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.35
Fwd PE 5.43
CMBT.BR Price Earnings VS Forward Price EarningsCMBT.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CMBT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CMBT is more expensive than 72.58% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.58
CMBT.BR Per share dataCMBT.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

CMBT has a very decent profitability rating, which may justify a higher PE ratio.
CMBT's earnings are expected to decrease with -29.06% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%

0

5. Dividend

5.1 Amount

No dividends for CMBT!.
Industry RankSector Rank
Dividend Yield N/A

CMB TECH NV

EBR:CMBT (7/1/2025, 7:00:00 PM)

7.72

-0.01 (-0.13%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners1.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.70B
Analysts80
Price Target11.47 (48.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend4.86
Dividend Growth(5Y)116.35%
DP109.72%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-99.31%
Min EPS beat(2)-149.02%
Max EPS beat(2)-49.61%
EPS beat(4)1
Avg EPS beat(4)9.95%
Min EPS beat(4)-149.02%
Max EPS beat(4)242.1%
EPS beat(8)5
Avg EPS beat(8)86.48%
EPS beat(12)8
Avg EPS beat(12)69.92%
EPS beat(16)10
Avg EPS beat(16)53.9%
Revenue beat(2)1
Avg Revenue beat(2)0.7%
Min Revenue beat(2)-9.81%
Max Revenue beat(2)11.21%
Revenue beat(4)3
Avg Revenue beat(4)5.75%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)15.33%
Revenue beat(8)6
Avg Revenue beat(8)28.28%
Revenue beat(12)10
Avg Revenue beat(12)38.19%
Revenue beat(16)14
Avg Revenue beat(16)43.66%
PT rev (1m)-6.2%
PT rev (3m)-14.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-19.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.72%
Valuation
Industry RankSector Rank
PE 7.35
Fwd PE 5.43
P/S 1.42
P/FCF N/A
P/OCF 7.42
P/B 1.55
P/tB 1.82
EV/EBITDA 10.58
EPS(TTM)1.05
EY13.6%
EPS(NY)1.42
Fwd EY18.42%
FCF(TTM)-3.65
FCFYN/A
OCF(TTM)1.04
OCFY13.49%
SpS5.42
BVpS4.97
TBVpS4.24
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROCE 6.75%
ROIC 5.06%
ROICexc 5.18%
ROICexgc 5.31%
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)8.95%
ROIC(5y)N/A
ROICexc(3y)9.88%
ROICexc(5y)N/A
ROICexgc(3y)9.93%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score2
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Debt/EBITDA 7.03
Cap/Depr 666.34%
Cap/Sales 86.55%
Interest Coverage 3.85
Cash Conversion 39.32%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.7
Altman-Z 0.66
F-Score2
WACC7.53%
ROIC/WACC0.67
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.01%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-100.41%
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.34%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-2.22%
Revenue Next Year7.15%
Revenue Next 2Y15.37%
Revenue Next 3Y9.37%
Revenue Next 5YN/A
EBIT growth 1Y-38.91%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year67.95%
EBIT Next 3Y22.95%
EBIT Next 5YN/A
FCF growth 1Y-783.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.61%
OCF growth 3YN/A
OCF growth 5Y11.04%